Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Barts & The London NHS Trust | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
This is an observational clinical study aiming to further the wider understanding of patients who develop persistent pain after Thoracoabdominal Aorta surgery, a surgical cohort who are disproportionately affected. This will be undertaken through a prospective biopsychosocial characterisation of the phenotype of patients undergoing this operation.
Increasing numbers of patients are undergoing surgery on the chest for treatment of heart or lung cancer disease. Over the last twenty years, the medical community has become increasingly aware of the long-term effect of this surgery in producing persistent pain, approximately half of all survivors are still in pain around their surgical incision at three months postoperatively and beyond. There is currently no accepted method for preventing this phenomenon.
The nervous system mechanisms for the development of persistent pain after surgery are unclear. Some studies suggest it may involve the patient's ability to dampen down pain signals travelling from the incision site to the brain.
Humans have an in-built system that produces opiates as well as other pain-relieving molecules in response to injury, e.g. surgery. However, this response varies hugely from person to person and may even be impacted by the psychological state of the individual at the time of surgery. Some of these pain modulating mechanisms can be measured before and after surgery in patients using sensory testing, a robust and established objective method to assess patients'.
Identifying patients who are most at risk of a persistent pain state will allow both academics and clinicians to investigate and better target appropriate treatments.
Undertaking these longitudinal observational assessments will facilitate an improved mechanistic insight of the transition from acute to pathological pain, with the ultimate goal of improving outcomes for patients'.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Develop Persistent Postsurgical Pain | Pain present 3 months post-op related to the surgical operation | ||
| Absence of Persistent Postsurgical Pain | Resolution of post-operative pain within the first three months of the operation |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Characterise the sensory phenotype of Persistent Postsurgical Pain following Thoracoabdominal Aortic Surgery with Quantitative Sensory Testing as a change measure. | Quantitative Sensory Tests (Pre-op, Early Post-operative Period, > 3 months Post-op) | 3 Years |
| Characterise the Pain Intensity as a change measure following Thoracoabdominal Aortic Surgery | Pain Intensity as measured by Visual Analogue Score (Pre-Op, Pre discharge, after three months post-op) | 3 years |
| Characterise the Pain Intensity as a change measure following Thoracoabdominal Aortic Surgery | Pain Intensity as measured by Numerical Rating Score (Pre-Op, Throughout the peri-op period and till 2 years post-op) | 3 years |
| Characterise the analgesia requirements as a change measure following Thoracoabdominal Aortic Surgery | Analgesic requirements as measured by oral morphine equivalents (Pre-Op, Throughout the peri-op period and till 2 years post-op) | 3 years |
| Characterise the analgesia requirements as a change measure following Thoracoabdominal Aortic Surgery | Non-opioid analgesic prescriptions (Pre-Op, Throughout the peri-op period and till 2 years post-op) | 3 years |
| Characterise the presence of neuropathic sensory phenotype of patients undergoing Thoracoabdominal Aortic Surgery pre-op, post-op and > 3 months post-op. | Neuropathic Pain as defined by Douleur Neuropathique 4 (DN4) (Pre-Op, > 3 months Post-op and till 2 years post-op) |
| Measure | Description | Time Frame |
|---|---|---|
| Determine the influence of baseline psychological and social profiles on postoperative pain outcomes. | Measured with Pain Catastrophising Scale (PCS) (Pre-Op, > 3 months Post-op) | 3 years |
| Determine the influence of baseline psychological and social profiles on postoperative pain outcomes. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adults Undergoing Elective Repair of the thoraco-abdominal aorta
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Brian Herath, MBBS | Contact | 00447870681640 | b.herath@nhs.net |
| Name | Affiliation | Role |
|---|---|---|
| Sibtain Anwar, MBBS MA PhD | Barts Health NHS Trust & Queen Mary University of London | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St Bartholomew's Hospital | Recruiting | London | EC1A 7BE | United Kingdom |
Anonymised data will be made available
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
Not provided
Not provided
Not provided
Acellular CSF and Plasma
| 3 years |
| Characterise the presence of neuropathic sensory phenotype of patients undergoing Thoracoabdominal Aortic Surgery pre-op, post-op and > 3 months post-op. | Neuropathic Pain as defined by Self Reported Leeds Assessment of Neuropathic Symptoms and Signs (SLANSS) (Pre-Op, > 3 months Post-op and till 2 years post-op) | 3 years |
| Characterise the change in biochemical phenotype pre-op and in the early post-op period following Thoracoabdominal Aortic Surgery and define significant differences between those with and without persistent post surgical pain | Multi regression analysis of CSF composition. | 3 Years |
| Characterise the change in biochemical phenotype pre-op and in the early post-op period following Thoracoabdominal Aortic Surgery and define significant differences between those with and without persistent post surgical pain | Multi regression analysis of blood composition. | 1 Week |
| Identify Predictors of Persistent Postsurgical Pain following Thoracoabdominal Aorta surgery | Determine if a composite biomarker or non response to conditioned pain modulation is a biomarker for development of persistent post-surgical pain and whether these are associated with biochemical differences through a bioinformatic data analysis approach. | 3 years |
Pain Anxiety Symptom Scale PASS20 as a change measure over time (Pre-Op, > 3 months Post-op) |
| 3 years |
| Determine the influence of baseline psychological and social profiles on postoperative pain outcomes. | Patient-Reported Outcomes Measurement Information System PROMIS: Fatigue and Sleep, depression and Anxiety as a change measure over time. (Pre-Op, > 3 months Post-op) | 3 years |
| Describe the impact of Persistent Post Surgical Pain on Quality of Life | Changes in EuroQual 5 Dimensions EQ5D. (Pre-Op, > 3 months Post-op and till 2 years post-op) | 3 years |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |